GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD
GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD
Not yet recruiting · NCT07747805 · Registry updated 2026-08-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD | Atrophy, Body Weight, Chronic Disease, Disease Attributes, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, muscular atrophy, nervous system disorder, nutritional disorder, obesity disorder, obstructive lung disease, overnutrition, respiratory system disorder | Not yet recruiting | Phase 2 | 2026-08-05 | NCT07747805 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The Cleveland Clinic | 239 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic | Cleveland | United States | 558 |